China Prescription Drug 2010 Issue 10 Development of Diet Pills Becomes a Hot Potato

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

China Prescription Drug
1671-945X
2010 Issue 10

Development of Diet Pills Becomes a Hot Potato

..............page:12

lun yao pin shi chang zhi er san shi

..............page:2

How to Regulate Off-label Drug Use, a Multi-perspective Exploration

..............page:23-25

Summary

..............page:72

ACEI, the Primary Blocker of RAS
zhang li ; liu guo shu

..............page:38-41

How to Conduct Clinical Trials in China?(Ⅱ)
zhu jun

..............page:10-11,67

dui chao shuo ming shu yong yao duo zhong yi yi shang de wan shan si kao
song ru liang

..............page:26-27

ke su lun tan jing cai fen cheng

..............page:31

xi jun nai yao zai qiao jing zhong

..............page:17

xin shen lian he sun hai zai lin chuang shang mian lin de yi xie wen ti
luo lei ming

..............page:33-35

xue guan jin zhang su shou ti zuo kang ji zai lao nian huan zhe zhong lin chuang ying yong yan jiu jin zhan
wang hai jun ; si quan jin

..............page:42-44

ji xing sui xi bao bai xue bing zhi liao de xin jin zhan
zhang zuo ; ma jun

..............page:46-49

an lin ting zai xue ye xi tong ji bing zhong de ying yong
li su xia ; zhu hong li

..............page:50-53

Off-label Drug Use, Pros and Cons from the View of Regulation and Science?

..............page:20-22

Amifostine in the Treatment of Blood System Diseases
jiang zuo

..............page:54-57

xue guan jin zhang su zhuan hua mei yi zhi ji de fa zhan zhi lu
zhang li ; liu guo shu

..............page:36-38

shi chang fa li , ru he tu chu zhong wei kang sheng su zhi shi chang xiao shou ji yan fa fen xi

..............page:58-59

yin du zhi yao qi ye de hai wai bing gou fen xi
liu yan ; yu zheng

..............page:68-69

Healthy Heart Revolution in Healthy China——Report from the 21st Great Wall International Congress of Cardiology(GW-ICC)

..............page:28-30

luo ge lie tong huo chen ai luo ding

..............page:16

RAS:the Target for Combined Control of Heart and Kidney Impairment
liu guo shu

..............page:32

xin xi dong tai

..............page:6-8,14-15,18-19,60-66

Analysis of Bias or Violation in Clinical Trials
fan da chao

..............page:70-71

yao pin zhi liang shi qi ye de wei yi sheng ming xian

..............page:13